6EHY
scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E SUPERBRIGHT |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-02-02 |
Detector | RIGAKU SATURN 944 |
Wavelength(s) | 1.54 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 48.061, 71.040, 121.252 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 44.680 - 2.250 |
R-factor | 0.231 |
Rwork | 0.228 |
R-free | 0.28500 |
Structure solution method | MIR |
RMSD bond length | 0.010 |
RMSD bond angle | 1.140 |
Data reduction software | d*TREK |
Data scaling software | d*TREK |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.6) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 48.060 |
High resolution limit [Å] | 2.250 |
Number of reflections | 20323 |
<I/σ(I)> | 6.2 |
Completeness [%] | 99.5 |
Redundancy | 5.59 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 7.5 | 293 | 4.5M NaCl 100mM HEPES pH 7.5 |